Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
11p13 | Aniridia | 106210 | AD | 3 | PAX6 | 607108 |
11p13 | Cataract with late-onset corneal dystrophy | 106210 | AD | 3 | PAX6 | 607108 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
11p13 | ?Aniridia 2 | AD | 3 | 617141 | ELP4 | 606985 |
11p13 | Aniridia | AD | 3 | 106210 | PAX6 | 607108 |
11p13 | Cataract with late-onset corneal dystrophy | AD | 3 | 106210 | PAX6 | 607108 |
11p13 | ?Aniridia 3 | AD | 3 | 617142 | TRIM44 | 612298 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
11p13 | Wilms tumor, type 1 | 194070 | AD, SMu | 3 | WT1 | 607102 |
13q13.1 | Wilms tumor | 194070 | AD, SMu | 3 | BRCA2 | 600185 |
Xq26.2 | Wilms tumor, somatic | 194070 | 3 | GPC3 | 300037 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
4q12 | {Wilms tumor 6, susceptibility to} | AD | 3 | 616806 | REST | 600571 |
7p14.1 | {Wilms tumor susceptibility-5} | AD, SMu | 3 | 601583 | POU6F2 | 609062 |
11p15.5 | Wilms tumor 2 | AD, SMu | 3 | 194071 | ICR1 | 616186 |
11p13 | Wilms tumor, type 1 | AD, SMu | 3 | 194070 | WT1 | 607102 |
13q13.1 | Wilms tumor | AD, SMu | 3 | 194070 | BRCA2 | 600185 |
16q | Wilms tumor, type 3 | AD | 2 | 194090 | WT3 | 194090 |
17q12-q21 | Wilms tumor, type 4 | AD | 2 | 601363 | WT4 | 601363 |
Xq26.2 | Wilms tumor, somatic | 3 | 194070 | GPC3 | 300037 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11p13 | Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome | 194072 | AD, SMu | 4 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11p13 | Denys-Drash syndrome | 194080 | AD, SMu | 3 |
Frasier syndrome | 136680 | AD, SMu | 3 | |
Meacham syndrome | 608978 | AD | 3 | |
Mesothelioma, somatic | 156240 | 3 | ||
Nephrotic syndrome, type 4 | 256370 | AD | 3 | |
Wilms tumor, type 1 | 194070 | AD, SMu | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11p13 | ?Coloboma of optic nerve | 120430 | AD | 3 |
?Morning glory disc anomaly | 120430 | AD | 3 | |
Aniridia | 106210 | AD | 3 | |
Anterior segment dysgenesis 5, multiple subtypes | 604229 | AD | 3 | |
Cataract with late-onset corneal dystrophy | 106210 | AD | 3 | |
Foveal hypoplasia 1 | 136520 | AD | 3 | |
Keratitis | 148190 | AD | 3 | |
Microphthalmia/coloboma 12 | 120200 | AD | 3 | |
Optic nerve hypoplasia | 165550 | AD | 3 |
|
|
|
|
|
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM